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Abstract: The spread of Streptococcus pneumoniae within families has been scarcely investigated so
far. This feasibility study aimed to estimate the prevalence of pneumococcal carriage in school-aged
children and co-habiting relatives and to explore the potential link between the family environment
and the sharing of pneumococcal serotypes covered by the vaccine. Oropharyngeal samples of
146 subjects belonging to 36 different family groups were molecularly tested for pneumococcal
detection and serotyping. The overall prevalence of pneumococcal carriage was 65.8% (n = 96/146),
whereas it was higher among schoolchildren (77.8%, n = 28/36); subjects of seven years of age had
the highest odds of being colonized (odds ratio, OR = 5.176; p = 0.145). Pneumococcal serotypes
included in the 13-valent conjugate vaccine formulation were largely detected in the study population
and multiple serotypes colonization was considerable. Factors relating to a close proximity among
people at the family level were statistically associated with pneumococcal carriage (OR = 2.121;
p = 0.049), as well as active smoking habit with a clear dose-response effect (ORs = 1.017–3.326).
About half of family clusters evidenced similar patterns of carried pneumococcal serotypes
and the odds of sustaining a high level of intrafamilial sharing increased with household size
(ORs = 1.083–5.000). This study highlighted the potential role played by the family environment in
sustaining both the circulation and horizontal transmission of pneumococcus.
Keywords: Streptococcus pneumoniae; conjugate vaccine; serotypes; schoolchildren; family; carriage;
colonization; horizontal transmission; real-time PCR
1. Introduction
Streptococcus pneumoniae is recognized as a commensal bacterium of the human upper respiratory
tract and the acquisition of nasopharyngeal carriage is considered to be the first step toward respiratory
and invasive pneumococcal disease (IPD) [1]. IPD occurs most frequently in children of five years
of age and under and in the elderly [2,3], and, in general, the high rates of IPD in younger children
correspond to higher prevalences of pneumococcal carriage [4,5]. The increasing frequency of bacterial
colonization in children may grow up to 90% in the first years of life, whereas a proportional decrease
of carriage prevalence by age has been described [6,7].
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In 2004, Sicily introduced the 7-valent pneumococcal conjugate vaccine (PCV7) into the regional
childhood immunization programme [8,9], reaching within a few years consistently high coverage
levels, near to 95%; in 2010, the vaccination schedule switched to the 13-valent formulation (PCV13) [10]
that aimed to provide a broader protection against IPD.
In accordance to other experiments conducted in Europe and USA [11–14], in Sicily
the immunization programme led to a consistent reduction of IPD in vaccinated children [15]. Due to
the burden of IPD in older adults [16,17] however, since 2014, the vaccination was also routinely
recommended for adults aged 65 years and older and for individuals from all age-groups at particularly
high risk for IPD, following a sequential schedule including a first dose of PCV13 eventually associated,
one year later, with one dose of the polysaccharide 23-valent (PPV23) formulation.
However, despite the free and active offer of vaccination, coverage rates in adults are still very
low, following a trend also observed in other countries [16,18–20].
Several authors have reported that high rates of vaccination coverage in childhood may result
in the herd immunity among unvaccinated subjects, protecting against disease caused by serotypes
included in vaccine formulations [21], but also preventing nasopharyngeal colonization [22].
Nevertheless, the potential effect of PCV on pneumococcal carriage is still debated and represents
a critical issue in terms of the positive pressure that may lead to a vaccine-induced serotype replacement
and the potential impact on the chain of transmission from vaccinated children to unprotected
adults/elderly in the social context [23].
In this sense, the international literature seems to suggest that the family environment may play
an active role in the circulation of current and emerging pneumococcal serotypes spreading through
household contacts [24].
Surveillance studies may provide insight into the dynamics of S. pneumoniae carriage within
families and household members. This is also potentially related to multiple pneumococcal strains,
which may co-exist in the upper respiratory tract of children in the first stages of their life [25,26].
Here we present a feasibility study that aimed to evaluate the oropharyngeal pneumococcal
carriage in a population of school-aged children and their co-habiting relatives, in order to identify
the contributing risk factors and determinants of sharing the PCV-included pneumococcal serotypes
into the family setting, as well as their implications on pneumococcal vaccination strategies dedicated
to adults/elderly.
2. Results
2.1. Subjects Characteristics
The study enrolled a total of 36 different schoolchildren (out of 189 invited students; 19.0%) of
which 12 attended first grade, 7 attended second grade, and 17 attended third grade of the selected
primary schools. The family-based group consisted of 110 subjects (out of 146; 75.3%), all members of
the 36 students’ family units (Table 1).
In general, participants to the study belonged to the lower-middle social class; for the adult
relatives, only 37.0% (n = 34/92) declared to have a job and only 29.3% (n = 27/92) had completed
an upper secondary education or obtained an academic degree.
More than half of the study population ≥12 years of age (52.2%; n = 48/92) was non-smoker;
33.3% (n = 16/48) reported to have been exposed to passive smoking. Active smoking habits were
documented in 47.8% of adult family members (n = 44/92), who started smoking, on average,
at 15 years of age and consuming about 15 cigarettes per day. In total, 15.7% of subjects (n = 23/146)
were regularly involved in sport activities (Table 1).
With regard to medical history, most family members declared to suffer of a pre-existing disease
(63.6%; n = 70/110), with hypertension as the most common among adults (32.4%; n = 22/68),
while only 11.1% of schoolchildren (n = 4/36) and 5.6% of their siblings (n = 1/18) presented
allergy-related symptoms.
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Table 1. Demographics, clinical characteristics and vaccination status of study participants.
Study Population Total School Children
Family Members
<12 Years ≥12 Years
Study participants (n (%)) 146 36 (24.7) 18 (12.3) 92 (63.0)
Age (years; median (IQR)) 31.0 (36.0) 7 (2.0) 5 (8.0) 39.0 (23.0)
Age-group (years)
5–6 22 (15.1) 12 (33.3) 10 (55.6) 0
7 9 (6.2) 8 (22.2) 1 (5.5) 0
8–11 23 (15.7) 16 (44.5) 7 (38.9) 0
12–25 (teenagers/young adults) 12 (8.2) 0 0 12 (13.1)
26–49 (adults) 52 (35.6) 0 0 52 (56.5)
≥50 (older adults/elderly) 28 (19.2) 0 0 28 (30.4)
Sex
Male 64 (43.8) 23 (63.9) 10 (55.6) 31 (33.7)
Female 82 (56.2) 13 (36.1) 8 (44.4) 61 (63.3)
Occupation (family members: ≥12 years of age, n = 92)
None 58 (63.0) 58 (63.0)
Employed 34 (37.0) 34 (37.0)
Level of education (family members: ≥12 years of age, n = 92)
None 10 (10.9) 10 (10.9)
Primary education 15 (16.3) 15 (16.3)
Lower secondary education 40 (43.5) 40 (43.5)
Upper secondary education 23 (25.0) 23 (25.0)
Academic degree 4 (4.3) 4 (4.3)
Smoking habit (family members: ≥12 years of age, n = 92)
Non-smokers 48 (52.2) 48 (52.2)
Passive smokers (n = 48) 16 (33.3) 16 (33.3)
Active smokers 44 (47.8) 44 (47.8)
Age of starting smoking (year; median (IQR)) 15 (4.5) 15 (4.5)
Number of cigarettes/cigars (n/day; median (IQR)) 15 (45) 15 (45)
Physical activity
Hours/week (n; median (IQR)) 3 (3) 2 (1) 2 (1) 5 (6)
Yes 23 (15.7) 8 (22.2) 4 (22.2) 11 (12.0)
Clinical features
Pre-existing diseases 78 (53.4) 8 (22.2) 2 (11.1) 68 (73.9)
Diabetes 2 (2.6) 0 0 2 (2.9)
Hypertension 22 (28.2) 0 0 22 (32.4)
Heart diseases 5 (6.4) 0 0 5 (7.3)
Chronic bronchitis/emphysema 8 (10.2) 0 0 8 (11.8)
Other 41 (52.6) 8 (100.0) # 2 (100.0) # 31 (45.6)
Vaccination status
Pneumococcal 46 (31.5) 31 (86.1) ∆ 13 (72.2) ∆∆ 2 (2.2) ∆∆∆
Complete vaccination schedule (n = 46) 41 (89.1) 30 (96.8) 10 (76.9) 1 (50.0)
Hexavalent 55 (38.7) 34 (94.4) 18 (100.0) 3 (3.3)
MMR 54 (37.0) 33 (91.7) 18 (100.0) 3 (3.3)
Varicella 47 (32.2) 29 (80.6) 15 (83.3) 3 (3.3)
Meningococcal C 13 (8.9) 5 (13.9) 7 (38.9) 1 (1.1)
Influenza (last 12 months) 8 (5.5) 1 (2.8) 0 7 (7.6)
IQR: interquartile range; Hexavalent: diphtheria, tetanus, acellular pertussis, Haemophilus influenzae type B,
poliovirus, and hepatitis B; MMR: measles, mumps, and rubella; # 50%, with allergy-related diseases;
∆ 7-valent pneumococcal conjugate vaccine (PCV7): 24 subjects; PCV7 + PCV13: 7 subjects; ∆∆ PCV7: 5 subjects;
PCV7 + PCV13: 3 subjects; PCV13: 5 subjects; ∆∆∆ PCV7: 1 subjects; PPV23: 1 subjects.
2.2. Vaccination Status
Data on immunization coverage were available for the entire study population. Pneumococcal vaccination
coverage was high among schoolchildren (86.1%; n = 31/36), whereas rates among households
consistently differed between siblings aged <12 years (72.2%; n = 13/18) and parents (2.2%; n = 2/92).
Overall, 86.9% (n = 40/46) of subjects <12 years of age (including schoolchildren and siblings)
completed the pneumococcal vaccination schedule (96.8%; n = 30/31 and 76.9%; n = 10/13,
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respectively); in more detail, 77.4% of schoolchildren (n = 24/31) received a complete schedule
of the 7-valent vaccine, while seven (22.6%) were vaccinated with PCV7 + PCV13.
Coverage rates for hexavalent and MMR were ≥90% among children, either among students
or siblings, while the percentages ranged between 80.6% and 83.3% for varicella vaccine; in general,
rates reported among adults were negligible.
As expected, meningococcal C vaccination coverage levels in the cohorts of children included
in our study population were low because of the vaccine introduction into the regional schedule
in 2010; the level of immunization against influenza was even lower (5.5%; n = 8/146) and most of
the vaccinated subjects were elderly (87.5%; n = 7/8).
2.3. Pneumococcal Carriage
Oropharyngeal colonization by S. pneumoniae was evaluated and an overall prevalence of 65.8%
(n = 96/146) was observed (Table 2). On the whole, the odds of carrying the pneumococcus among
students was about two times higher than that observed in the group of family members (OR = 2.161;
p = 0.084), and the probability was the highest among children aged seven years (OR = 5.176, p = 0.145).
The comparison by gender showed a slight association with females (OR = 1.143; p = 0.704).
Table 2. Main socio-demographic characteristics and vaccination status of the study population,
according to pneumococcal colonization (lytA-pos vs. lytA-neg).
Study Population
Pneumococcal Colonization (lytA-pos)
p-Value Odds Ratio (95% CI)
No Yes
Study participants (n = 146), (n (%)) 50 (34.2) 96 (65.8)
Schoolchildren 8 (22.2) 28 (77.8) 0.084 2.161 (0.901–5.185)
Family members 42 (38.2) 68 (61.8) (reference)
Age-group (years)
5–6 8 (36.4) 14 (63.6) 0.833 1.132 (0.357–3.587)
7 1 (11.1) 8 (88.9) 0.145 5.176 (0.566–47.323)
8–11 5 (21.7) 18 (78.3) 0.184 2.329 (0.669–8.112)
12–25 2 (16.7) 10 (83.3) 0.175 3.235 (0.593–17.658)
26–49 23 (44.2) 29 (55.8) 0.670 0.816 (0.320–2.079)
≥50 11 (39.3) 17 (60.7) (reference)
Sex
Male 23 (35.9) 41 (64.1) (reference)
Female 27 (32.9) 55 (67.1) 0.704 1.143 (0.574–2.273)
Crowding index
Low 37 (40.2) 55 (59.8) (reference)
High 13 (24.1) 41 (75.9) 0.049 2.121 (1.002–4.492)
Smoking habit (family members: ≥12 years of age, n = 92)
Non-smokers 23 (46.0) 27 (54.0) (reference)
Active smokers 13 (30.9) 29 (69.1) 0.143 1.900 (0.805–4.484)
Number of cigarettes/cigars per day
<5 cigarettes/day 22 (39.3) 34 (60.7) (reference)
≥5 cigarettes/day 14 (38.9) 22 (61.1) 0.970 1.017 (0.431–2.399)
<10 cigarettes/day 28 (44.4) 35 (55.6) (reference)
≥10 cigarettes/day 8 (27.6) 21 (72.4) 0.127 2.100 (0.809–5.451)
<15 cigarettes/day 32 (43.8) 41 (56.2) (reference)
≥15 cigarettes/day 4 (21.0) 15 (79.0) 0.078 2.927 (0.885–9.678)
<20 cigarettes/day 33 (43.4) 43 (56.6) (reference)
≥20 cigarettes/day 3 (18.8) 13 (81.2) 0.078 3.326 (0.875–12.634)
Physical activity
Yes 9 (39.1) 14 (60.9) (reference)
No 41 (33.3) 82 (66.7) 0.591 1.286 (0.514–3.218)
Pre-existing respiratory diseases
No 30 (38.5) 48 (61.5) (reference)
Yes 20 (29.4) 48 (70.6) 0.251 1.500 (0.750–2.999)
Crowding index—“High” identifies families consisting of three persons or more and living in a dwelling with
four rooms or less; Respiratory co-morbidities—At least one of the following disease: asthma, chronic bronchitis,
nasal obstruction, allergic rhinitis, sinusitis, otitis, tonsillectomy, adenoidectomy.
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Factors relating to a close proximity among people were summarized in the “crowding index” and
this supported a borderline statistically significant association with pneumococcal carriage (OR = 2.121;
p = 0.049).
Active smoking potentially correlated to pneumococcal colonization (OR = 1.900; p = 0.143) with
a clear dose-response trend (OR range: 1.017–3.326) (Table 2). Also, pneumococcal carriage was more
frequently detected (OR = 1.286, p = 0.591) in those not engaged in regular physical activity, as well as
in individuals with pre-existing respiratory diseases (OR = 1.500, p = 0.251).
The number of PCV13 serotypes carried per person was also investigated. Almost all
the 96 colonized study participants harbored more than one serotype, and the relative proportions
followed a normal distribution (Figure 1). In general, about half of all colonized individuals had
three to four different serotypes in their oropharynx, whereas less than seven percent of persons
carried only one pneumococcal serotype; notably, about 30.0% of them harbored five to eight different
pneumococcal serotypes.
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with the serotypes 19 B/F, 7 V/A and 18 B/C being the most common (range: 12.9%–25.7%), whereas 
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Table 3 reports the level of intrafamilial sharing of pneumococcal serotypes within each family 
context, expressed as percentages. 
In detail, the denominator was calculated as the total number of positive rt-PCR tests for PCV13 
serotypes among all individuals in the household, including the student. Conversely, the numerator 
consisted of the whole number of positive rt-PCR results, among all other members of the same family, 
for those pneumococcal serotypes identified in oropharyngeal specimen collected from the related 
student. 
For each family-cluster, the ratio was arbitrarily assumed to provide an estimate of measurement 
for the intrafamilial spread of pneumococcus. 
According to the calculated percentages, the whole family setting was divided into quartiles, 16 
out of 36 family groups fell between the 3rd and 4th quartile, and the score 50% was arbitrarily chosen 
in order to identify two different groups defined at “low” or “high” pneumococcal intrafamilial sharing. 
Figure 1. l ti ti f t s r t i e tifie in oropharyngeal s ab
speci ens collected fro healthy subjects positive for Streptococ us pneumoniae (co-colonization).
Figure 2 illustrates the distribution of pneumococcal serotypes detected in oropharyngeal swab
specimens. In general, no differences were found between schoolchildren and household contacts,
with the serotypes 19 B/F, 7 V/A and 18 B/C being the most common (range: 12.9%–25.7%),
whereas the frequency of detection of the other PCV13 serotypes was consistently lower than 10%.
Table 3 reports the level of intrafamilial sharing of pneumococcal serotypes within each family
context, expressed as percentages.
In detail, the denominator was calculated as the total number of positive rt-PCR tests for PCV13
serotypes among all individuals in the household, including the student. Conversely, the numerator
consisted of the whole number of positive rt-PCR results, among all other members of the same
family, for those pneumococcal serotypes identified in oropharyngeal specimen collected from
the related student.
For each family-cluster, the ratio was arbitrarily assumed to provide an estimate of measurement
for the intrafamilial spread of pneumococcus.
According to the calculated percentages, the whole family setting was divided into quartiles,
16 out of 36 family groups fell between the 3rd and 4th quartile, and the score 50% was arbitrarily chosen
in order to identify two different groups defined at “low” or “high” pneumococcal intrafamilial sharing.
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Figure 2. Distribution of PCV13 serotype (in ranking order) of colonizing pneumococcal strains
collected from schoolchildren and household contacts. Bar graphs indicate the percentage of each
serotype determined in relation to the total number of identified serotypes in the study period.
Labels including the character “/” identify potential cross-reacting molecular targets.
Table 3. Intrafamilial sharing of pneumococcal serotypes, expressed as percentage of detected serotypes
in common between household contacts and student, selected as reference.
ID Family Nu ber Student Age (Reference Case) H usehold Size Intrafamilial Sharing (%)
14 8 2 100.0
23 9 5 90.9
2 8 5 90.5
11 6 4 84.6
34 7 7 81.2
12 8 3 75.0
25 6 3 75.0
33 9 2 75.0
16 7 7 1.4
3 9 5 70.8
20 8 3 69.2
6 8 4 68.7
28 11 4 68.7
19 8 9 65.2
26 7 3 60.0
27 6 5 50.0
10 7 5 47.0
30 8 4 46.7
5 7 3 44.4
21 6 5 42.9
17 8 4 25.0
31 7 4 18.2
1 8 5 0
4 6 2 0
7 6 4 0
8 6 3 0
9 7 3 0
13 7 4 0
15 6 6 0
18 6 3 0
22 8 1 0
24 8 5 0
29 6 3 0
32 8 5 0
35 6 2 0
36 6 4 0
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Thus, the univariate analysis was performed with the aim of exploring the potential role of specific
socio-demographic contexts suggestive of crowded environments in the households and still positively
associated with pneumococcal carriage (Table 4).
Table 4. Socio-demographic variables and pneumococcal intrafamilial sharing, according to low (≤50%)
and high score (>50%).
Intrafamilial Sharing
p-Value Odds Ratio (95% CI)
Low High
Family clusters (n = 36), (n (%)) 21 (58.3) 15 (41.7)
Crowding index
Low 15 (62.5) 9 (37.5) (reference)
High 6 (50.0) 6 (50.0) 0.475 1.667 (0.410–6.767)
Household size
≤2 persons 3 (60.0) 2 (40.0) (reference)
>2 persons 18 (58.1) 13 (41.9) 0.935 1.083 (0.158–7.435)
≤3 persons 9 (60.0) 6 (40.0) (reference)
>3 persons 12 (57.1) 9 (42.9) 0.864 1.125 (0.292–4.326)
≤4 persons 15 (65.2) 8 (34.8) (reference)
>4 persons 6 (46.1) 7 (53.9) 0.269 2.188 (0.546–8.761)
≤5 persons 20 (62.5) 12 (37.5) (reference)
>5 persons 1 (25.0) 3 (75.0) 0.184 5.000 (0.466–53.682)
Crowding index: “High” identifies families consisting of three persons or more and living in a dwelling with
four rooms or less.
In particular, the “crowding index” suggested a potential correlation with the intrafamilial sharing
of pneumococcus (OR = 1.667; p = 0.475), and the odds increased with the increasing household size
(ORs range: 1.083–5.000).
3. Discussion
Studies on pneumococcal colonization in children have been widely undertaken [21,27–29].
However, the contribution of PCV immunized children to bacterial spread among their unvaccinated
co-habiting relatives has not been investigated so far.
This study evaluated the pneumococcal colonization among school-aged children and their
households and it aimed to define both the prevalence of carriage and the potential spread of
bacterial serotypes within family clusters. Although our study was strongly limited by the low
rate of schoolchildren participation, some consideration can be drawn.
Overall, we found a carriage prevalence of 65.8% and seven year-old schoolchildren showed
the highest rate of pneumococcal colonization.
In general, both values and trends documented here are in agreement with other studies
conducted in Italy [29–32], although a comparison is difficult due to different population settings and
pneumococcal detection methods (i.e., cultural or molecular-based).
Some community- and household-level factors previously shown to have independent effects on
childhood pneumococcal carriage [33] were analysed in this project.
Pneumococcal carriage was inversely related to the number of rooms in the house but directly
related to household size, thus suggesting that such factors might play an important role in sustaining
the overall circulation of pneumococcal strains at the family-level. These findings were in accordance
with Menezes et al. [34], who recently described the same pathway among children in an urban
community characterized by crowded environments in the households.
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The effect of exposure to tobacco smoke on pneumococcal colonization has been debated in
the literature and there is an overall agreement that both active and passive smoking are independent
risk factors for carriage [35], as well as for invasive S. pneumoniae infections [36,37].
In this context, Le Rouzic and colleagues [38] recently reported that cigarette smoke might
alter the ability to activate the antigen specific T-cell response of the human immune system against
Streptococcus pneumoniae.
However, results from different studies substantially reflect the population setting considered.
Indeed, Camilli and colleagues [28] indicated a strong association between pneumococcal carriage in
children and a smoking mother in the household, while van Hoek et al. [23] recognized both a slight
positive effect of passive smoke and consistently higher odds among active smokers aged 18 years
or above. In our paper, we found a positive effect of active smoking on pneumococcal carriage,
although this was not significant, and the odds progressively increased with the number of cigarettes
smoked per day.
Furthermore, other individual and clinical factors such as the lack of physical activities as well
as pre-existing respiratory diseases may also increase the risk of being colonized by pneumococcus
in our setting. Zuccotti et al. [32], in Italy, found that the occurrence of respiratory tract infections in
the previous three months since bacterial detection, might represent a predictor of nasopharyngeal
pneumococcal carriage in healthy children aged 3–59 months.
The potential role of pneumococcal vaccination on carriage remains a critical issue and it is
still widely discussed in the scientific literature. It may typically depend on the carriage prevalence
in the general population, the immunological status of vaccinated subjects and, not least, the time
elapsed since the last PCV dose assumption. In this regard, it has been suggested that the rate
of colonization consistently declines in the first year from PCV and then gradually increases in
the following years [29,39]. Moreover, Principi and colleagues [31] reported a higher proportion of
carriers among vaccinated healthy children and adolescents, irrespective of pneumococcal serotypes
included either in 7-valent or 13-valent formulations.
Conversely, Zuccotti and colleagues [32] in a larger study found comparable pneumococcal
carriage rates in vaccinated and unvaccinated children less than five years of age, as also observed
by Lakshman et al. [40] in UK among children aged two to five years living in a largely unvaccinated
population, thus suggesting that PCV immunization does not necessarily interact with the microbial
persistence in the upper respiratory tract.
The cohort of schoolchildren enrolled in our study reflects the overall high vaccination coverage
against pneumococcus achieved in Sicily and, according to their birth cohorts, the participants to
the study were mainly immunized with the 7-valent vaccine formulation.
Nevertheless, five of the seven most commonly identified serotypes in this study represented
PCV13 serotypes and were detected at similar frequencies from the oropharynx of schoolchildren and
their household contacts, irrespective of vaccination status.
These findings are in accordance to those proposed by Principi et al. [31] in Italy, suggesting that no
relevant serotype replacement may have occurred in our geographic area, although the cross-sectional
design of our study cannot permit to draw conclusions on this topic.
Notwithstanding, this issue is still far from being cleared in light of other studies on carriage
performed after PCV7 implementation in childhood, which assessed a lower carriage rate in vaccinated
than in unvaccinated subjects together with a consistent reduction of PCV7 serotypes [41–44].
The multiple carriage of Streptococcus pneumoniae has been already reported by several
authors [27,45,46], proving that the number of concurrent serotypes detected strongly depends on
the technique used [23,47,48], and molecular-based studies, like this study, inevitably provide a higher
number of serotypes simultaneously carried in the oropharynx.
In our cohort, almost all subjects had more than one serotype in their oropharynx and,
unexpectedly, the total number per individual followed a nearly normal distribution, with three to five
concurrent serotypes as the most frequent setting. A similar trend was observed in a rural setting of
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African children [49], while conflicting dynamics were recently reported in unvaccinated [45] or highly
vaccinated population groups [29], among which the number of simultaneous serotypes was higher,
and the relative abundance of subjects involved was lower.
Such evidence may have serious implications in increased opportunities for intra-host horizontal
gene transfer, which may lead to capsule switch, antibiotic resistance and vaccine escape [45,50].
The most outstanding ecological feature of S. pneumoniae in this study was the clustering
propensity of serotypes into families. To date, some authors have explored the dynamics of bacterial
colonization within only mother-infant pairs, with the mothers as possible source of carriage [49,51].
Conversely, as far as we know, the pattern of spread of S. pneumoniae within family clusters was
previously investigated in the second half of nineties [52–55], whereas it was scarcely explored in
the PCV era.
Our experiment underlined a consistent proportion of family groups whose members shared
the same pattern of pneumococcal serotypes carried by the schoolchildren, suggesting a potential
horizontal transfer of bacteria among household contacts also facilitated by crowded settings.
This circumstance may have important implications in the intrafamilial spread of PCV and
non-PCV serotypes driven by vaccinated children toward unvaccinated adults and elderly, who may
become colonized and, therefore, susceptible to potentially developing pneumococcal disease.
Of course, our study has some limitations. First, it was a pilot study conducted in a healthy
population of two selected primary schools and this limited the statistical power of the study.
Second, due to the cross-sectional design of this study and because of the recent introduction of
PCV13 in Sicily, it may only represent a snapshot of the current situation in a geographic area
characterized by high pneumococcal vaccine coverage in childhood and it is unable to predict trend
changes in pneumococcal carriage serotypes. Third, it should be mentioned that rt-PCR molecular
methods, in some cases, may cross-react with non-PCV serotypes and this could affect the results.
However, we are reasonably confident that the reported PCV13 serotypes distribution adequately
reflected the local epidemiological scenario, in accordance with the current scientific evidence from
other recent Italian studies [28,32].
Nevertheless, the strength of our study is the lack of previous similar experiments, providing us
the opportunity to describe the potential role played by the family environment in sustaining
both the circulation of pneumococcal serotypes and the horizontal transmission of carriage toward
unvaccinated susceptible household contacts.
In conclusion, although the present work aimed to demonstrate the feasibility in our area,
these findings provide baseline information on the dynamics of carriage that would be worth
considering on a larger scale and further investigated on different target populations.
Further epidemiological studies and the continuous surveillance of targeted populations are
needed to improve the understanding of the dynamics of transmission and carriage, in order to
implement new control strategies and to improve actual preventive measures.
4. Materials and Methods
4.1. Study Population
This pilot surveillance study was named BINOCOLO, an Italian acronym for “children
and grandparents joined together against pneumococcus”, and it took place between April and
October 2014.
Two primary schools located in the metropolitan area of Palermo were selected to participate in
the study. In the Italian Education System, primary school consists of three different grade attended by
children 6 years old (first grade), 7 years old (second grade), and 8 years old (third grade), respectively.
Following the school manager approval, six classes were randomly identified in one school
(two first grades, two second grades and two third grades, respectively), while the other school
contributed with four classes of students (two first grades and two third grades, respectively).
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The “school-based” recruitment was followed by a “family-based” recruitment of household
contacts of the students that joined the project (i.e., brothers and sisters, parents, grandparents,
uncles). In this phase, the family clusters of the study were defined and a recapture sampling for
missed recruitments at school was carried out. Each cluster included all family members living in
the same household.
Two different structured questionnaires were validated and used to collect information among
children (7 sections accounting for 80 items) and adults (7 sections accounting for 75 items),
including individual and socio-demographic data, lifestyles, underlying medical conditions,
influenza-like symptoms, and vaccination history.
Each participant (child/adult) was requested to answer the questionnaire and to be sampled
by oropharyngeal swab. According to family cluster willingness, meetings for questionnaire
administration and sampling were performed either at the University Hospital of Palermo
“P. Giaccone”, Department of Health Promotion Sciences and Mother-Child Care “G. D’Alessandro” at
the University of Palermo (Sicily), or at their home. Each participant received a testimonial gadget at
the end of the study.
4.2. Ethics Statement
Parents and cohabiting relatives of the schoolchildren were convened for an informative meeting,
which was held in the presence of both the manager and qualified teachers of participating schools.
During each meeting, objectives, methods, design and expected results of the study were declared
and a leaflet that synthetically reproduced the content of the presentation and working group contacts
was also distributed. At the end of each meeting, parents and all members of participating families
were asked to give formal written consent for themselves and for their children.
The study was approved by the medical ethics committee of the University Hospital of Palermo
with the protocol number 13 (11 December 2013).
4.3. Laboratory Methods
Oropharyngeal samples were collected from each participating subject. After collection, the swabs
were placed in skim-milk-tryptone-glucose-glycerin (STGG) transport medium according to WHO
guidelines [56,57] and stored at −80 ◦C until further analysis.
Bacterial DNA was extracted and purified using the QIAamp DNA mini kit (Qiagen, Valencia, CA,
USA) following the manufacturer’s protocol with a few modifications. Briefly, 180 µL of each sample
was added with 80 µL of lysozyme (20 mg/mL in 20 mM Tris-HCl, pH 8.0, 2 mM EDTA, 1.2% Triton)
and incubated at 37 ◦C for 30 min. Following the addition of 20 µL of proteinase K (0.5 mg/mL in
Tris-HCl 20 mM, pH 8.0) and 200 µL of the lysis buffer provided with the kit, the mixture was further
incubated at 56 ◦C per 30 min, and the enzyme subsequently denatured at 95 ◦C for 15 min. All other
steps were followed as per the manufacturer’s instructions to a final volume of 100 µL elution buffer.
Carriage of Streptococcus pneumoniae was evaluated by means of a single-plex real-time PCR
(rt-PCR) assay for the detection of pneumococcal autolysin (lytA) gene sequence [57], and a sample
was assumed to be negative if there was no increase in fluorescent signal after 40 rt-PCR cycles.
All lytA positive samples were included in serotyping analysis by means of single-plex rt-PCR
assays for the detection of specific genetic segments of pneumococcal serotypes/serogroups covered
by the 13-valent conjugate vaccine (1, 3, 4, 5, 6A/B, 7A/F, 9V/A, 14, 18B/C, 19A, 19B/F, 23F),
as previously described by Azzari et al. [47]. To this end, all molecular tests were carried out in
duplicate, including both negative and plasmid positive controls of each PCV13 serotype.
4.4. Statistical Analysis
Descriptive statistics were used to summarize each of the socio-demographic and clinical variables
included in the questionnaires (counts, percentages, median and interquartile range, as appropriate).
Int. J. Mol. Sci. 2017, 18, 105 11 of 15
The study population was stratified into six age groups. In detail, children were grouped
according to the age range for school attendance (5–6, 7 and 8 years old, respectively), while the other
subjects were arbitrarily clustered into further three age groups including teenagers/young adults
(12–25 years old), adults (26–49 years old) and older adults/elderly (≥50 years old).
Moreover, an indicator of the level of crowding in a private dwelling was identified—the “crowding
index”—with the aim of exploring the possible relationships between factors relating to a close
proximity of co-habiting individuals (i.e., the number of household members, the number of rooms
in the dwelling) and the pneumococcus carriage within each family cluster. To this end, a dummy
variable was arbitrarily defined in order to represent a group of families consisting of three persons or
more and living in a dwelling with four rooms or less.
Therefore, potential risk factors for pneumococcal carrier status were investigated by univariate
logistic regression analysis and the strength of association was expressed as odds ratios (ORs) and
95% confidence intervals (CI).
All of the analyses with p-values of 0.05 or less were considered to be statistically significant
(two tailed). Data were processed with the STATA MP statistical software package v14.1 for Apple™
(StataCorp, College Station, TX, USA).
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